Clinical trials: Scar Improvement
Wound Healing, Abdominal Surgery
Management of Abdominal Post-surgical Scar With Ozoaqua Versus Standard Care
A prospective, randomized clinical study with a blinded evaluator to compare a post-surgical abdominal scar care protocol using Ozoaqua products versus standard care in patients undergoing open abdominal surgery.
- Conditions
- Wound Healing, Abdominal Surgery, Scar Improvement
- Trial name
- NCT07678372
- Testing
- Ozonated product-based protocol for scar hygiene and care
- Where
- Spain
- Volunteers
- 144 people
- Sponsor
- Laboratorios Ozoaqua
Burn, Hypertrophic Scars
Carbon Dioxide Laser-Assisted Delivery of Triamcinolone With or Without 5-Fluorouracil for Hypertrophic Burn Scars
Burn scars can sometimes heal in a way that causes them to become thick, raised, and stiff. These scars may itch, feel uncomfortable, limit movement, and affect how the skin looks.
- Conditions
- Burn, Hypertrophic Scars, Scar Improvement by Laser, CO2 Laser in Scars
- Trial name
- NCT07660120
- Testing
- Fractional Ablative CO₂ Laser, Triamcinolone Acetonide, Fluorouracil (5-FU)
- Volunteers
- 65 people
- Sponsor
- University of California, Davis
Scar Improvement, Cosmetic Outcome
Tape Application Protocol for Enhanced Scars
What is the purpose of this study? The Investigators want to find out whether applying Micropore surgical tape to the medial half of the mastectomy scar for 3 months helps improve its appearance after 12 months, compared to no…
- Trial name
- TAPES (NCT07144046)
- Testing
- Micropore covering of the medial half of the scar
- Volunteers
- 90 people
- Sponsor
- Herlev Hospital
Scar Improvement by Laser
Laser Treatment in Early Wound Healing to Promote Physiological Skin Remodeling
The primary objective of this study is to explore the potential clinical effect of targeting surgical wounds in all three wound healing phases by non ablative fractional laser (NAFL) to reduce scar formation in a randomized…
- Trial name
- NCT03253484
- Testing
- NAFL-treatment
- Volunteers
- 32 people
- Sponsor
- Bispebjerg Hospital
Scar Improvement
A Trial to Compare the Efficacy of Two Formulations of Avotermin Against Placebo
RN1006 has been developed as a stabilized formulation of avotermin which, when dosed once in pre-clinical studies in animals, has shown comparable scar improvement efficacy to the standard twice-dosed Juvista formulation.
- Trial name
- RN1006 (NCT01029158)
- Testing
- Juvista (Avotermin), RN1006 (Avotermin)
- Where
- United Kingdom
- Volunteers
- 84 people, healthy volunteers welcome
- Sponsor
- Renovo